Yifan Pharmaceutical Co Ltd
SZSE:002019
Income Statement
Earnings Waterfall
Yifan Pharmaceutical Co Ltd
Revenue
|
4B
CNY
|
Cost of Revenue
|
-2.1B
CNY
|
Gross Profit
|
1.9B
CNY
|
Operating Expenses
|
-1.8B
CNY
|
Operating Income
|
135.8m
CNY
|
Other Expenses
|
-890.4k
CNY
|
Net Income
|
134.9m
CNY
|
Income Statement
Yifan Pharmaceutical Co Ltd
Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
656
N/A
|
1 158
+77%
|
1 331
+15%
|
1 487
+12%
|
1 726
+16%
|
1 685
-2%
|
1 930
+15%
|
2 237
+16%
|
2 446
+9%
|
2 435
0%
|
2 664
+9%
|
2 949
+11%
|
3 282
+11%
|
3 505
+7%
|
3 548
+1%
|
3 630
+2%
|
3 900
+7%
|
4 373
+12%
|
4 760
+9%
|
4 842
+2%
|
4 742
-2%
|
4 632
-2%
|
4 515
-3%
|
4 824
+7%
|
4 994
+4%
|
5 187
+4%
|
5 376
+4%
|
5 480
+2%
|
5 533
+1%
|
5 400
-2%
|
5 276
-2%
|
4 967
-6%
|
4 656
-6%
|
4 409
-5%
|
4 115
-7%
|
3 801
-8%
|
3 740
-2%
|
3 837
+3%
|
3 869
+1%
|
4 011
+4%
|
4 038
+1%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(485)
|
(798)
|
(898)
|
(965)
|
(1 106)
|
(1 012)
|
(1 152)
|
(1 360)
|
(1 469)
|
(1 462)
|
(1 585)
|
(1 637)
|
(1 766)
|
(1 737)
|
(1 706)
|
(1 758)
|
(1 750)
|
(1 877)
|
(2 100)
|
(2 270)
|
(2 480)
|
(2 592)
|
(2 749)
|
(2 857)
|
(2 864)
|
(2 809)
|
(2 766)
|
(2 737)
|
(2 824)
|
(2 899)
|
(3 063)
|
(3 033)
|
(2 849)
|
(2 594)
|
(2 324)
|
(2 053)
|
(1 926)
|
(1 983)
|
(2 059)
|
(2 110)
|
(2 129)
|
|
Gross Profit |
171
N/A
|
360
+110%
|
433
+20%
|
522
+21%
|
621
+19%
|
673
+8%
|
777
+16%
|
878
+13%
|
977
+11%
|
973
0%
|
1 079
+11%
|
1 311
+22%
|
1 516
+16%
|
1 768
+17%
|
1 842
+4%
|
1 872
+2%
|
2 150
+15%
|
2 497
+16%
|
2 660
+7%
|
2 572
-3%
|
2 262
-12%
|
2 040
-10%
|
1 766
-13%
|
1 967
+11%
|
2 130
+8%
|
2 377
+12%
|
2 610
+10%
|
2 742
+5%
|
2 709
-1%
|
2 501
-8%
|
2 213
-12%
|
1 934
-13%
|
1 807
-7%
|
1 815
+0%
|
1 791
-1%
|
1 748
-2%
|
1 814
+4%
|
1 853
+2%
|
1 810
-2%
|
1 902
+5%
|
1 909
+0%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(165)
|
(210)
|
(241)
|
(290)
|
(364)
|
(369)
|
(414)
|
(465)
|
(528)
|
(593)
|
(648)
|
(682)
|
(707)
|
(832)
|
(852)
|
(795)
|
(804)
|
(875)
|
(880)
|
(951)
|
(987)
|
(1 072)
|
(1 099)
|
(1 128)
|
(1 207)
|
(1 185)
|
(1 337)
|
(1 390)
|
(1 368)
|
(1 359)
|
(1 322)
|
(1 411)
|
(1 452)
|
(1 511)
|
(1 508)
|
(1 536)
|
(1 640)
|
(1 654)
|
(1 712)
|
(1 774)
|
(1 773)
|
|
Selling, General & Administrative |
(123)
|
(197)
|
(239)
|
(286)
|
(349)
|
(340)
|
(406)
|
(454)
|
(518)
|
(527)
|
(611)
|
(644)
|
(663)
|
(688)
|
(785)
|
(776)
|
(748)
|
(726)
|
(765)
|
(811)
|
(874)
|
(867)
|
(910)
|
(969)
|
(1 028)
|
(1 039)
|
(1 122)
|
(1 111)
|
(1 098)
|
(1 088)
|
(1 142)
|
(1 212)
|
(1 267)
|
(1 266)
|
(1 348)
|
(1 382)
|
(1 486)
|
(1 444)
|
(1 480)
|
(1 519)
|
(1 484)
|
|
Research & Development |
0
|
(8)
|
0
|
0
|
0
|
(20)
|
0
|
0
|
0
|
(41)
|
0
|
0
|
0
|
(105)
|
0
|
0
|
(45)
|
(137)
|
0
|
0
|
(85)
|
(162)
|
(125)
|
(164)
|
(192)
|
(202)
|
(244)
|
(248)
|
(233)
|
(316)
|
(307)
|
(318)
|
(309)
|
(187)
|
(194)
|
(190)
|
(194)
|
(180)
|
(199)
|
(212)
|
(235)
|
|
Depreciation & Amortization |
0
|
(4)
|
0
|
0
|
0
|
(8)
|
0
|
0
|
0
|
(24)
|
0
|
0
|
0
|
(37)
|
0
|
0
|
0
|
(46)
|
0
|
0
|
0
|
(58)
|
0
|
0
|
0
|
(83)
|
0
|
0
|
0
|
(82)
|
0
|
0
|
0
|
(103)
|
0
|
0
|
0
|
(66)
|
0
|
0
|
0
|
|
Other Operating Expenses |
(42)
|
(0)
|
(2)
|
(5)
|
(15)
|
(1)
|
(8)
|
(11)
|
(10)
|
(2)
|
(37)
|
(38)
|
(45)
|
(1)
|
(67)
|
(19)
|
(11)
|
34
|
(115)
|
(140)
|
(29)
|
15
|
(64)
|
5
|
14
|
138
|
29
|
(30)
|
(36)
|
127
|
126
|
118
|
124
|
44
|
34
|
36
|
40
|
37
|
(33)
|
(43)
|
(55)
|
|
Operating Income |
7
N/A
|
150
+2 179%
|
192
+28%
|
232
+21%
|
256
+11%
|
304
+19%
|
363
+20%
|
413
+14%
|
449
+9%
|
381
-15%
|
431
+13%
|
630
+46%
|
808
+28%
|
935
+16%
|
991
+6%
|
1 077
+9%
|
1 346
+25%
|
1 621
+20%
|
1 780
+10%
|
1 621
-9%
|
1 275
-21%
|
968
-24%
|
668
-31%
|
839
+26%
|
924
+10%
|
1 192
+29%
|
1 273
+7%
|
1 352
+6%
|
1 341
-1%
|
1 142
-15%
|
891
-22%
|
523
-41%
|
355
-32%
|
304
-15%
|
282
-7%
|
213
-25%
|
174
-18%
|
199
+15%
|
97
-51%
|
128
+31%
|
136
+6%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(1)
|
3
|
15
|
25
|
34
|
0
|
(10)
|
(11)
|
(6)
|
(8)
|
8
|
4
|
(14)
|
(16)
|
(29)
|
(48)
|
(62)
|
(86)
|
(129)
|
(62)
|
(14)
|
(5)
|
19
|
(5)
|
1
|
(47)
|
0
|
(21)
|
(70)
|
(56)
|
(52)
|
(68)
|
(68)
|
(80)
|
(94)
|
(77)
|
(67)
|
(31)
|
(34)
|
(35)
|
(57)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
(5)
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
(33)
|
0
|
(14)
|
(13)
|
(29)
|
(1)
|
(1)
|
(0)
|
(72)
|
(2)
|
(2)
|
2
|
(73)
|
(0)
|
(1)
|
(6)
|
(7)
|
0
|
(1)
|
(1)
|
(15)
|
14
|
15
|
15
|
(28)
|
0
|
1
|
3
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
(2)
|
(2)
|
(5)
|
(7)
|
(5)
|
(6)
|
0
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
(4)
|
2
|
1
|
1
|
1
|
3
|
2
|
3
|
72
|
72
|
74
|
73
|
5
|
8
|
29
|
29
|
27
|
24
|
7
|
2
|
4
|
(6)
|
(8)
|
(7)
|
(8)
|
(4)
|
(9)
|
(5)
|
(8)
|
1
|
10
|
13
|
15
|
2
|
(3)
|
(4)
|
(5)
|
16
|
3
|
0
|
10
|
|
Pre-Tax Income |
2
N/A
|
156
+8 544%
|
208
+34%
|
258
+24%
|
291
+13%
|
301
+4%
|
355
+18%
|
402
+13%
|
513
+27%
|
444
-13%
|
506
+14%
|
701
+39%
|
793
+13%
|
895
+13%
|
990
+11%
|
1 044
+5%
|
1 298
+24%
|
1 530
+18%
|
1 657
+8%
|
1 560
-6%
|
1 265
-19%
|
885
-30%
|
677
-24%
|
825
+22%
|
920
+11%
|
1 068
+16%
|
1 263
+18%
|
1 325
+5%
|
1 258
-5%
|
1 081
-14%
|
849
-21%
|
467
-45%
|
302
-35%
|
211
-30%
|
199
-6%
|
146
-27%
|
117
-20%
|
157
+34%
|
66
-58%
|
94
+42%
|
92
-2%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(1)
|
(38)
|
(53)
|
(67)
|
(76)
|
(64)
|
(74)
|
(76)
|
(92)
|
(82)
|
(92)
|
(145)
|
(197)
|
(211)
|
(251)
|
(264)
|
(298)
|
(265)
|
(268)
|
(236)
|
(161)
|
(191)
|
(157)
|
(178)
|
(187)
|
(195)
|
(216)
|
(223)
|
(221)
|
(149)
|
(115)
|
(55)
|
(12)
|
31
|
30
|
45
|
33
|
(30)
|
0
|
(13)
|
(14)
|
|
Income from Continuing Operations |
1
|
117
|
155
|
191
|
215
|
238
|
281
|
327
|
420
|
362
|
414
|
556
|
596
|
683
|
739
|
780
|
1 000
|
1 266
|
1 389
|
1 324
|
1 103
|
694
|
520
|
647
|
733
|
873
|
1 048
|
1 103
|
1 037
|
931
|
734
|
412
|
289
|
242
|
228
|
191
|
150
|
127
|
67
|
82
|
78
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(1)
|
(1)
|
(2)
|
(2)
|
7
|
21
|
29
|
42
|
45
|
39
|
42
|
40
|
37
|
44
|
40
|
36
|
36
|
30
|
32
|
34
|
36
|
37
|
43
|
52
|
59
|
36
|
39
|
35
|
41
|
64
|
68
|
58
|
57
|
|
Net Income (Common) |
4
N/A
|
118
+2 700%
|
155
+32%
|
191
+23%
|
215
+12%
|
238
+11%
|
281
+18%
|
327
+16%
|
420
+29%
|
361
-14%
|
413
+15%
|
554
+34%
|
604
+9%
|
705
+17%
|
768
+9%
|
822
+7%
|
1 045
+27%
|
1 305
+25%
|
1 431
+10%
|
1 364
-5%
|
1 140
-16%
|
737
-35%
|
559
-24%
|
683
+22%
|
769
+12%
|
904
+18%
|
1 080
+20%
|
1 136
+5%
|
1 073
-6%
|
968
-10%
|
777
-20%
|
463
-40%
|
348
-25%
|
278
-20%
|
267
-4%
|
226
-16%
|
191
-15%
|
191
+0%
|
135
-30%
|
139
+3%
|
135
-3%
|
|
EPS (Diluted) |
0.01
N/A
|
0.21
+2 000%
|
0.29
+38%
|
0.35
+21%
|
0.39
+11%
|
0.37
-5%
|
0.44
+19%
|
0.5
+14%
|
0.64
+28%
|
0.55
-14%
|
0.63
+15%
|
0.6
-5%
|
0.54
-10%
|
0.64
+19%
|
0.69
+8%
|
0.75
+9%
|
0.94
+25%
|
1.15
+22%
|
1.18
+3%
|
1.12
-5%
|
0.95
-15%
|
0.61
-36%
|
0.46
-25%
|
0.56
+22%
|
0.63
+13%
|
0.73
+16%
|
0.88
+21%
|
0.91
+3%
|
0.88
-3%
|
0.79
-10%
|
0.63
-20%
|
0.35
-44%
|
0.29
-17%
|
0.23
-21%
|
0.22
-4%
|
0.19
-14%
|
0.16
-16%
|
0.16
N/A
|
0.11
-31%
|
0.1
-9%
|
0.11
+10%
|